Julie Champion is the William R. McLain Endowed Term Professor in the School of Chemical and Biomolecular Engineering at Georgia Institute of Technology. She earned her B.S.E. in chemical engineering from the University of Michigan and Ph.D. in chemical engineering at the University of California Santa Barbara. She was an NIH postdoctoral fellow at the California Institute of Technology. Champion is a fellow of the American Institute for Medical and Biological Engineering and has received awards including American Chemical Society Women Chemists Committee Rising Star, NSF BRIGE Award, Georgia Tech Women in Engineering Faculty Award for Excellence in Teaching, Georgia Tech BioEngineering Program Outstanding Advisor Award. Professor Champion’s current research focuses on design and self-assembly of functional nanomaterials made from engineered proteins for applications in immunology, cancer, and biocatalysis.

Sam Brown's lab studies the multi-scale dynamics of infectious disease. Their goal is to improve the treatment and control of infectious diseases through a multi-scale understanding of microbial interactions. Their approach is highly interdisciplinary, combining theory and experiment, evolution, ecology and molecular microbiology in order to understand and control the multi-scale dynamics of bacteria pathogens.

Blair Brettmann received her B.S. in chemical engineering at the University of Texas at Austin in 2007. She received her Master’s in chemical engineering practice from MIT in 2009 following internships at GlaxoSmithKline (Upper Merion, PA) and Mawana Sugar Works (Mawana, India). Blair received her Ph.D. in chemical engineering at MIT in 2012 working with the Novartis-MIT Center for Continuous Manufacturing under Professor Bernhardt Trout. Her research focused on solid-state characterization and application of pharmaceutical formulations prepared by electrospinning. Following her Ph.D., Brettmann worked as a research engineer for Saint-Gobain Ceramics and Plastics for two years. While at Saint-Gobain she worked on polymer-based wet coatings and dispersions for various applications, including window films, glass fiber mats and architectural fabrics. Later, Brettmann served as a postdoctoral researcher in the Institute for Molecular Engineering at the University of Chicago with Professor Matthew Tirrell. Currently, Brettmann is an assistant professor with joint appointments in chemical and biomolecular engineering and Materials Science and Engineering at Georgia Tech.

Edward Botchwey received a B.S. in mathematics from the University of Maryland at College Park in 1993 and both M.E. and Ph.D. degrees in materials science engineering and bioengineering from the University of Pennsylvania in 1998 and 2002 respectively. He was recruited to the faculty at Georgia Tech in 2012 from his previous position at the University of Virginia. His current position is associate professor in the Wallace H. Coulter Department of Biomedical Engineering at Georgia Tech and Emory University. Botchwey is former Ph.D. fellow of the National GEM Consortium, a former postdoctoral fellow of the UNCF-Merk Science Initiative, and a recipient of the Presidential Early Career Awards for Scientists and Engineers from the National Institutes of Health. 

Botchwey’s research focuses on the delivery of naturally occurring small molecules and synthetic derivatives for applications in tissue engineering and regenerative medicine. He is particularly interested in how transient control of immune response using bioactive lipids can be exploited to control trafficking of stem cells, enhance tissue vascularization, and resolve inflammation. Botchwey serves on the Board of Directors of the Biomedical Engineering Society (BMES) and serves as the secretary to the Biomedical Engineering Decade committee.

Botchwey, his wife Nisha Botchwey (also a GT faculty member) and three children reside in east Atlanta in the Lake Claire neighborhood. Botchwey is also an avid cyclist and enjoys reading YA fantasy, behavioral neuroscience and Christian theology books in his personal time.

Dr. Borodovsky and his group develop machine learning algorithms for computational analysis of biological sequences: DNA, RNA and proteins. Our primary focus is on prediction of protein-coding genes and regulatory sites in genomic DNA. Probabilistic models play an important role in the algorithm framework, given the probabilistic nature of biological sequence evolution.

Andreas (Andy) S. Bommarius is a professor of Chemical and Biomolecular Engineering as well of Chemistry and Biochemistry at the Georgia Institute of Technology in Atlanta, GA.  He received his diploma in Chemistry in 1984 at the Technical University of Munich, Germany and his Chemical Engineering B.S. and Ph.D. degrees in 1982 and 1989 at MIT, Cambridge, MA.

From 1990-2000, he led the Laboratory of Enzyme Catalysis at Degussa (now Evonik) in Wolfgang, Germany, where his work ranged from immobilizing homogenous catalysts in membrane reactors to large-scale cofactor-regenerated redox reactions to pharma intermediates.

At Georgia Tech since 2000, his research interests cover green chemistry and biomolecular engineering, specifically biocatalyst development and protein stability studies.  His lab applies data-driven protein engineering to improve protein properties on catalysts ranging from ene and nitro reductases to cellobiohydrolases.  Bommarius has guided the repositioning of the curriculum towards Chemical and Biomolecular Engineering by developing new courses in Process Design, Biocatalysis and Metabolic Engineering, as well as Drug Design, Development, and Delivery (D4), an interdisciplinary course with Mark Prausnitz.

Andy Bommarius in 2008 became a Fellow of the American Institute of Medical and Biological Engineering.  Since 2010, he is Director of the NSF-I/UCR Center for Pharmaceutical Development (CPD), a Center focusing on process development, drug substance and product stability, and novel analytical methods for the characterization of drug substances and excipients.

Saad Bhamla studies biomechanics across species to engineer knowledge and tools that inspire curiosity.

Saad Bhamla is an assistant professor of biomolecular engineering at Georgia Tech. A self-proclaimed "tinkerer," his lab is a trove of discoveries and inventions that span biology, physics and engineering. His current projects include studying the hydrodynamics of insect urine, worm blob locomotion and ultra-low-cost devices for global health. His work has appeared in the New York Times, the Economist, CNN, Wired, NPR, the Wall Street Journal and more.

Saad is a prolific inventor and his most notable inventions includes a 20-cent paper centrifuge, a 23-cent electroporator, and the 96-cent hearing aid. Saad's work is recognised by numerous awards including a NIH R35 Outstanding Investigator Award, NSF CAREER Award, CTL/BP Junior Faculty Teaching Excellence Award, and INDEX: Design to Improve Life Award. Saad is also a National Geographic Explorer and a TED speaker. Newsweek recognized Saad as 1 of 10 Innovators disrupting healthcare.

Saad is a co-founder of Piezo Therapeutics.

Outside of the lab, Saad loves to go hiking with his partner and two dogs (Ollie and Bella).

Dr. Jianhua Xiong is an Assistant Professor of Urology at Emory University School of Medicine. The laboratory investigates the metabolic regulation of cell fate and function, with a focus on urological disorders and cancer. Research explores how fatty acids influence cell behavior in T cells, endothelial cells, and cancer cells. A multidisciplinary approach integrates cell and molecular biology, biochemistry, super-resolution imaging, transcriptomics, proteomics, metabolomics, histology, tissue studies, and mouse models to understand cellular mechanisms and identify potential therapeutic strategies.

Dr. Gary W. Liu is an Assistant Professor of Biomedical Engineering at Georgia Institute of Technology and Emory School of Medicine. He received his B.S. in Biomedical Engineering from The University of Texas at Austin, and his Ph.D. in Bioengineering from the University of Washington, Seattle. He conducted his postdoctoral fellowship at Massachusetts Institute of Technology. Dr. Liu's research and mentorship have been recognized by the following: Ruth L. Kirschstein NRSA, K99/R00 Pathway to Independence Award, Excellence in Mentorship Award, and nomination for the Peter Karches Mentorship Prize. His research group seeks to develop new diagnostics and therapeutics for kidney medicine.